These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8324166)

  • 1. Clinical relevance of susceptibility testing of anaerobic bacteria.
    Rosenblatt JE; Brook I
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S446-8. PubMed ID: 8324166
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a need for the antibiotic susceptibility testing of anaerobic bacteria?
    Nagy E; Schuetz A
    Anaerobe; 2015 Feb; 31():2-3. PubMed ID: 25464139
    [No Abstract]   [Full Text] [Related]  

  • 3. Chapter 1-3. Anaerobic infections (general): drug susceptibility tests.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():26-30. PubMed ID: 21728086
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial susceptibility patterns of anaerobic bacteria in relation to therapy.
    García-Rodríguez J; García-Sánchez J
    Chemioterapia; 1987 Jun; 6(2 Suppl):49-52. PubMed ID: 3509479
    [No Abstract]   [Full Text] [Related]  

  • 5. A survey of susceptibility testing of anaerobes in the United Kingdom.
    Andrews JM; Wise R
    J Antimicrob Chemother; 2002 Nov; 50(5):757. PubMed ID: 12407138
    [No Abstract]   [Full Text] [Related]  

  • 6. EUCAST invite comments on new methods for antimicrobial susceptibility testing of anaerobic bacteria.
    Kahlmeter G; Morris TE
    Anaerobe; 2021 Aug; 70():102417. PubMed ID: 34314866
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.
    Jacobus NV; Immermann FW; Gupte JM; Testa RT
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S344-8. PubMed ID: 8391862
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
    Grossmeyer TJ; Farmer SG
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S353-6. PubMed ID: 8324146
    [No Abstract]   [Full Text] [Related]  

  • 9. Chapter 2-2. Anaerobic infections (individual fields): blood stream infections with anaerobic bacteria.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():47-9. PubMed ID: 21728091
    [No Abstract]   [Full Text] [Related]  

  • 10. Chapter 2-1. Anaerobic infections (individual fields): respiratory infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():42-6. PubMed ID: 21728090
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefoxitin in the treatment of aerobic and anaerobic infections. Prospective correlation of in vitro susceptibility methods with clinical outcome.
    Goldstein EJ; Citron DM; Cole RE; Rangel DM; Seid AS; Ostovari MO
    Hosp Pract (Off Ed); 1990 Oct; 25 Suppl 4():38-45. PubMed ID: 2120272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Apr; 43(2):139-42. PubMed ID: 11217270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of nonsporing anaerobes to ten antimicrobial agents.
    Rao PS; Shivananda PG
    Indian J Pathol Microbiol; 2000 Jul; 43(3):281-4. PubMed ID: 11218673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antibiotic susceptibilities of anaerobes associated with infections of the female reproductive tract.
    Madinger NE; McGregor JA; McKinney PJ; Dembeck ST; Haskell CS; Johnson Z
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S349-52. PubMed ID: 8324145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anaerobic bacteria in various infections and their antibiotic susceptibility patterns].
    Tunçkanat F; Günalp A
    Mikrobiyol Bul; 1986 Oct; 20(4):230-41. PubMed ID: 3657617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between in vitro susceptibility data of anaerobes to ceftizoxime and clinical response.
    Wikler MA; Moonsammy GI; Nichols RL
    J Chemother; 1989 Jul; 1(4 Suppl):660-1. PubMed ID: 16312580
    [No Abstract]   [Full Text] [Related]  

  • 17. Current perspectives on anaerobic infections: diagnostic approaches.
    Finegold SM; Jousimies-Somer HR; Wexler HM
    Infect Dis Clin North Am; 1993 Jun; 7(2):257-75. PubMed ID: 8345169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of faropenem activity against anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Bryskier A
    J Chemother; 2005 Feb; 17(1):36-45. PubMed ID: 15828442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():4-12. PubMed ID: 21728084
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial susceptibility testing of anaerobic bacteria: review, comments, and opinions.
    Thornsberry C
    Ann Otol Rhinol Laryngol Suppl; 1991 Sep; 154():7-10. PubMed ID: 1952686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.